Eman L. Dadashian

698 total citations
8 papers, 536 citations indexed

About

Eman L. Dadashian is a scholar working on Genetics, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Eman L. Dadashian has authored 8 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 3 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Eman L. Dadashian's work include Chronic Lymphocytic Leukemia Research (4 papers), Immunodeficiency and Autoimmune Disorders (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Eman L. Dadashian is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Immunodeficiency and Autoimmune Disorders (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Eman L. Dadashian collaborates with scholars based in United States, China and Denmark. Eman L. Dadashian's co-authors include Hong Wu, Marcus Ruscetti, David J. Mulholland, Adrian Wiestner, Sarah E. M. Herman, Erika M. Cook, Christoph Rader, Junpeng Qi, Yu Xing and Peter S. Nelson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Cancer Research.

In The Last Decade

Eman L. Dadashian

8 papers receiving 531 citations

Peers

Eman L. Dadashian

ONCOL

MB

GENET

CR

IMMUN

Siobhan Glavey United States

Hoiseon Jeong South Korea

Sameer A. Greenall Australia

Lisa Roberts-Rapp United States

Anna N. Cvrljevic Australia

Amir Hossein Daneshmanesh Sweden

Daniel Trageser United States

Jamie L. DellaGatta United States

Tiffany Khong Australia

Sarah Brennan United States

Siobhan Glavey United States

Eman L. Dadashian

315 ×1.0

ONCOL

499 ×2.1

MB

96 ×0.7

GENET

117 ×0.9

CR

206 ×1.7

IMMUN

Citations per year, relative to Eman L. Dadashian Eman L. Dadashian (= 1×) peers Siobhan Glavey

Countries citing papers authored by Eman L. Dadashian

Since Specialization

Citations

This map shows the geographic impact of Eman L. Dadashian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eman L. Dadashian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eman L. Dadashian more than expected).

Fields of papers citing papers by Eman L. Dadashian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eman L. Dadashian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eman L. Dadashian. The network helps show where Eman L. Dadashian may publish in the future.

Co-authorship network of co-authors of Eman L. Dadashian

This figure shows the co-authorship network connecting the top 25 collaborators of Eman L. Dadashian. A scholar is included among the top collaborators of Eman L. Dadashian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eman L. Dadashian. Eman L. Dadashian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Ma, Runzhuo, Eman L. Dadashian, Alvin C. Goh, et al.. (2024). MP73-20 WHERE TO START YOUR NERVE-SPARING IN ROBOTIC-ASSISTED RADICAL PROSTATECTOMY: LATERAL PROSTATIC FASCIA VERSUS PROSTATIC PEDICLE. The Journal of Urology. 211(5S). 1 indexed citations

2.

Dadashian, Eman L., Erin M. McAuley, Delong Liu, et al.. (2018). TLR Signaling Is Activated in Lymph Node–Resident CLL Cells and Is Only Partially Inhibited by Ibrutinib. Cancer Research. 79(2). 360–371. 44 indexed citations

3.

Qi, Junpeng, Xiuling Li, Haiyong Peng, et al.. (2018). Potent and selective antitumor activity of a T cell-engaging bispecific antibody targeting a membrane-proximal epitope of ROR1. Proceedings of the National Academy of Sciences. 115(24). E5467–E5476. 62 indexed citations

4.

Robinson, Hannah R., Junpeng Qi, Erika M. Cook, et al.. (2018). A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era. Blood. 132(5). 521–532. 89 indexed citations

5.

Niemann, Carsten Utoft, Helena Mora-Jensen, Eman L. Dadashian, et al.. (2017). Combined BTK and PI3Kδ Inhibition with Acalabrutinib and ACP-319 Improves Survival and Tumor Control in CLL Mouse Model. Clinical Cancer Research. 23(19). 5814–5823. 25 indexed citations

6.

Saba, Nakhle S., Deanna H. Wong, Patricia Lobelle‐Rich, et al.. (2017). MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. Cancer Research. 77(24). 7038–7048. 40 indexed citations

7.

Ruscetti, Marcus, et al.. (2015). Tracking and Functional Characterization of Epithelial–Mesenchymal Transition and Mesenchymal Tumor Cells during Prostate Cancer Metastasis. Cancer Research. 75(13). 2749–2759. 173 indexed citations

8.

Ruscetti, Marcus, Eman L. Dadashian, Weilong Guo, et al.. (2015). HDAC inhibition impedes epithelial–mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer. Oncogene. 35(29). 3781–3795. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact